LegoChem Biosciences, Inc - Product Pipeline Review - 2016

  • ID: 3759018
  • Company Profile
  • 37 pages
  • Global Markets Direct
1 of 4
LegoChem Biosciences, Inc - Product Pipeline Review - 2016

Summary

‘LegoChem Biosciences, Inc - Product Pipeline Review - 2016’, provides an overview of the LegoChem Biosciences, Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by LegoChem Biosciences, Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of LegoChem Biosciences, Inc
- The report provides overview of LegoChem Biosciences, Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses LegoChem Biosciences, Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features LegoChem Biosciences, Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate LegoChem Biosciences, Inc’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for LegoChem Biosciences, Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding LegoChem Biosciences, Inc’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

LegoChem Biosciences, Inc Snapshot

LegoChem Biosciences, Inc Overview

Key Information

Key Facts

LegoChem Biosciences, Inc - Research and Development Overview

Key Therapeutic Areas

LegoChem Biosciences, Inc - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

LegoChem Biosciences, Inc - Pipeline Products Glance

LegoChem Biosciences, Inc - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

LegoChem Biosciences, Inc - Drug Profiles

LCB-010699

Product Description

Mechanism of Action

R&D Progress

LCB-030110

Product Description

Mechanism of Action

R&D Progress

LCB-100200

Product Description

Mechanism of Action

R&D Progress

LCB-140110

Product Description

Mechanism of Action

R&D Progress

LCB-1414XX

Product Description

Mechanism of Action

R&D Progress

LCB-141XXX

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugate for Undisclosed Indication

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein 1 for Cancer

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein 2 for Cancer

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Anaplastic Lymphoma Kinase for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Blood Factor XIa for CAHD and Stroke

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Hypoxia inducible factor-1 for Ophthalmology

Product Description

Mechanism of Action

R&D Progress

LegoChem Biosciences, Inc - Pipeline Analysis

LegoChem Biosciences, Inc - Pipeline Products by Target

LegoChem Biosciences, Inc - Pipeline Products by Route of Administration

LegoChem Biosciences, Inc - Pipeline Products by Molecule Type

LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action

LegoChem Biosciences, Inc - Dormant Projects

LegoChem Biosciences, Inc - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

LegoChem Biosciences, Inc, Key Information

LegoChem Biosciences, Inc, Key Facts

LegoChem Biosciences, Inc - Pipeline by Indication, 2016

LegoChem Biosciences, Inc - Pipeline by Stage of Development, 2016

LegoChem Biosciences, Inc - Monotherapy Products in Pipeline, 2016

LegoChem Biosciences, Inc - Partnered Products in Pipeline, 2016

LegoChem Biosciences, Inc - Partnered Products/ Combination Treatment Modalities, 2016

LegoChem Biosciences, Inc - Out-Licensed Products in Pipeline, 2016

LegoChem Biosciences, Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016

LegoChem Biosciences, Inc - Preclinical, 2016

LegoChem Biosciences, Inc - Discovery, 2016

LegoChem Biosciences, Inc - Pipeline by Target, 2016

LegoChem Biosciences, Inc - Pipeline by Route of Administration, 2016

LegoChem Biosciences, Inc - Pipeline by Molecule Type, 2016

LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action, 2016

LegoChem Biosciences, Inc - Dormant Developmental Projects,2016

List of Figures

LegoChem Biosciences, Inc - Pipeline by Top 10 Indication, 2016

LegoChem Biosciences, Inc - Pipeline by Stage of Development, 2016

LegoChem Biosciences, Inc - Monotherapy Products in Pipeline, 2016

LegoChem Biosciences, Inc - Out-Licensed Products in Pipeline, 2016

LegoChem Biosciences, Inc - Pipeline by Target, 2016

LegoChem Biosciences, Inc - Pipeline by Route of Administration, 2016

LegoChem Biosciences, Inc - Pipeline by Molecule Type, 2016

LegoChem Biosciences, Inc - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll